Regeneron Pharmaceuticals revenue was $8.5 b in FY, 2020 which is a (8.1%) year over year increase from the previous period.
Regeneron Pharmaceuticals revenue breakdown by business segment: 65.5% from Product Sales, 27.9% from Sanofi and Bayer Collaboration and 6.6% from Other
|FY, 2020||FY, 2019||FY, 2018|
|Sanofi and Bayer Collaboration||$2.37 b||$2.62 b||$2.19 b|
|Product Sales||$5.57 b||$4.83 b||$4.11 b|
|Other||$557 m||$413.4 m||$416.8 m|
Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.